Optimal Management of Hereditary Angioedema: Shared Decision-Making

por Banerji, Aleena, Anderson, John, Johnston, Douglas T
Publicado 2021

Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential

por Blumenthal, Kimberly G., Castells, Mariana, Banerji, Aleena
Publicado 2021

Delayed onset urticaria and symptomatic dermographism following COVID‐19 booster vaccination: A case series

por Drivenes, Jakob Lillemoen, Banerji, Aleena, Bygum, Anette
Publicado 2022

Rapid progress in our understanding of COVID-19 vaccine allergy: A cause for optimism, not hesitancy

por Banerji, Aleena, Norton, Allison E., Blumenthal, Kimberly G., Stone, Cosby A., Phillips, Elizabeth
Publicado 2022

Treatment Outcomes and Adverse Drug Reactions Associated with Ceftaroline Use

por Blumenthal, Kimberly, Kuhlen, James, Weil, Ana, Varughese, Christy, Kubiak, David W., Banerji, Aleena, Shenoy, Erica S.
Publicado 2015

Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain

por Staller, Kyle, Lembo, Anthony, Banerji, Aleena, Bernstein, Jonathan A., Shah, Eric D., Riedl, Marc A.
Publicado 2022

Urticaria after COVID-19 vaccination and vaccine hesitancy

por Judd, Allen, Samarakoon, Upeka, Wolfson, Anna R., Banerji, Aleena, Freeman, Esther E., Blumenthal, Kimberly G.
Publicado 2023

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies

por Busse, Paula J., Farkas, Henriette, Banerji, Aleena, Lumry, William R., Longhurst, Hilary J., Sexton, Daniel J., Riedl, Marc A.
Publicado 2018

Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study

por Johnston, Douglas T., Busse, Paula J., Riedl, Marc A., Maurer, Marcus, Anderson, John, Nurse, Christina, Inhaber, Neil, Yu, Ming, Banerji, Aleena
Publicado 2021

Ceftaroline Desensitization Procedure in a Pregnant Patient With Multiple Drug Allergies

por Kuhlen, James L., Blumenthal, Kimberly G., Sokol, Caroline L., Balekian, Diana S., Weil, Ana A., Varughese, Christy A., Shenoy, Erica S., Banerji, Aleena
Publicado 2015

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

por Riedl, Marc A, Banerji, Aleena, Manning, Michael E, Burrell, Earl, Joshi, Namita, Patel, Dipen, Machnig, Thomas, Tai, Ming-Hui, Watson, Douglas J
Publicado 2018

Reply to “PEG skin testing for COVID-19 allergy”

por Banerji, Aleena, Phillips, Elizabeth, Saff, Rebecca, Wickner, Paige G., Robinson, Lacey B., Wolfson, Anna R., Williams, Paul, Khan, David A., Blumenthal, Kimberly G.
Publicado 2021

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey

por Banerji, Aleena, Baş, Murat, Bernstein, Jonathan A., Boccon-Gibod, Isabelle, Bova, Maria, Dempster, John, Grumach, Anete Sevciovic, Magerl, Markus, Poarch, Kimberly, Ferreira, Manuel Branco
Publicado 2016

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach

por Banerji, Aleena, Wolfson, Anna R., Wickner, Paige G., Cogan, Amelia S., McMahon, Aubree E., Saff, Rebecca, Robinson, Lacey B., Phillips, Elizabeth, Blumenthal, Kimberly G.
Publicado 2021

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks

por Riedl, Marc A., Maurer, Marcus, Bernstein, Jonathan A., Banerji, Aleena, Longhurst, Hilary J., Li, H. Henry, Lu, Peng, Hao, James, Juethner, Salomé, Lumry, William R.
Publicado 2020

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study

por Lumry, William R., Weller, Karsten, Magerl, Markus, Banerji, Aleena, Longhurst, Hilary J., Riedl, Marc A., Lewis, Hannah B., Lu, Peng, Devercelli, Giovanna, Jain, Gagan, Maurer, Marcus
Publicado 2020

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2

por Blumenthal, Kimberly G., Freeman, Esther E., Saff, Rebecca R., Robinson, Lacey B., Wolfson, Anna R., Foreman, Ruth K., Hashimoto, Dean, Banerji, Aleena, Li, Lily, Anvari, Sara, Shenoy, Erica S.
Publicado 2021

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing

por Wolfson, Anna R., Robinson, Lacey B., Li, Lily, McMahon, Aubree E., Cogan, Amelia S., Fu, Xiaoqing, Wickner, Paige, Samarakoon, Upeka, Saff, Rebecca R., Blumenthal, Kimberly G., Banerji, Aleena
Publicado 2021

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study

por Banerji, Aleena, Bernstein, Jonathan A., Johnston, Douglas T., Lumry, William R., Magerl, Markus, Maurer, Marcus, Martinez‐Saguer, Inmaculada, Zanichelli, Andrea, Hao, James, Inhaber, Neil, Yu, Ming, Riedl, Marc A.
Publicado 2021

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

por Banerji, Aleena, Wickner, Paige G., Saff, Rebecca, Stone, Cosby A., Robinson, Lacey B., Long, Aidan A., Wolfson, Anna R., Williams, Paul, Khan, David A., Phillips, Elizabeth, Blumenthal, Kimberly G.
Publicado 2021